PULMONARY EMBOLISM IN BREAST CANCER: ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT APPROACHES

Cover Page


Cite item

Full Text

Abstract

Pulmonary embolism in breast cancer is one of the causes of major deterioration of health status of the patients. Pulmonary artery occlusion is most often a  consequence of venous thromboembolism; this condition is referred to as "pulmonary thromboembolism". Significantly less common cause of occlusion of the pulmonary artery branches can be embolism by a  cluster of tumor cells, accompanied by development of pulmonary tumor thrombotic microangiopathy. This paper reviews data on the etiology and pathogenesis of pulmonary embolism in breast cancer, and approaches to its prevention and treatment.

About the authors

I. D. Rozanov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: andreybalkanov@yandex.ru
MD, Department of Radiology Russian Federation

E. A. Rozanova

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: andreybalkanov@yandex.ru
Resident, Chair of Diagnostic Radiology, Postgraduate Training Faculty Russian Federation

E. I. Shirikov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: andreybalkanov@yandex.ru
Resident, Chair of Oncology and Thoracic Surgery, Postgraduate Training Faculty Russian Federation

A. S. Balkanov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Author for correspondence.
Email: andreybalkanov@yandex.ru
MD, PhD, Head of Department of Radiology Russian Federation

L. E. Gaganov

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: andreybalkanov@yandex.ru
MD, PhD, Chief of Department of Pathological Anatomy Russian Federation

E. A. Stepanova

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: andreybalkanov@yandex.ru
MD, PhD, Roentgenologist, Department of X-ray Computed Tomography and Magnetic Resonance Imaging; Assistant Lecturer, Chair of Diagnostic Radiology, Postgraduate Training Faculty Russian Federation

References

  1. Гуров АН, Балканов АС, Катунцева НА, Огнева ЕЮ. Анализ онкозаболеваемости и смертности населения Московской области за 2014 год. Альманах клинической медицины. 2015;41:6–11. doi: 10.18786/2072-0505-2015-41-6-11.
  2. Vanitha MK, Sakthisekaran D, Anandaku-mar P. Breast cancer: types, epidemiology & aeitiology, a review. Adv J Pharm Life Sci Res. 2014;2(4): 29–38.
  3. Ay C, Dunkler D, Pirker R, Thaler J, Quehen-berger P, Wagner O, Zielinski C, Pabinger I. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8): 1158–64. doi: 10.3324/haematol.2011.054718.
  4. von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic micro-angiopathy with pulmonary hypertension. Cancer. 1990;66(3): 587–92. doi: 10.1002/1097-0142(19900801)66:33.0.CO;2-J.
  5. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2): 62–9. doi: 10.1053/j.seminhematol.2007.02.004.
  6. Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 2003;107(23 Suppl 1):I17–21. doi: 10.1161/01. CIR.0000078466.72504.AC.
  7. Розанов ИД, Семашкова АЕ, Балка-нов АС, Терпигорев СА, Степанова ЕА. Тромбоэмболия легочной артерии: некоторые вопросы эпидемиологии и лечения у онкологических пациентов. Альманах клинической медицины. 2015;41:97–102. doi: 10.18786/2072-0505-2015-41-97-102.
  8. Hernandez RK, Sørensen HT, Pedersen L, Jacobsen J, Lash TL. Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study. Cancer. 2009;115(19): 4442–9. doi: 10.1002/cncr.24508.
  9. Kirwan CC, Byrne GJ, Kumar S, McDowell G. Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer. J Angiogenes Res. 2009;1:7. doi: 10.1186/2040-2384-1-7.
  10. Yang Y, Choi Y, Beom SH, Kim JW, Joen YK, Kim NJ, Kim JH, Im SA, Lee KH. A case report of breast cancer with extensive pulmonary lymphovascular tumor emboli. J Breast Cancer. 2012;15(1): 128–32. doi: 10.4048/ jbc.2012.15.1.128.
  11. Mehrishi S, Awan A, Mehrishi A, Fein A. Pulmonary tumor microembolism. Hosp Physician. 2004;40(1): 23–30.
  12. Kostadima E, Zakynthinos E. Pulmonary embolism: pathophysiology, diagnosis, treatment. Hellenic J Cardiol. 2007;48(2): 94–107.
  13. Kyriazi V. Breast cancer as an acquired thrombophilic state. J Breast Cancer. 2012;15(2): 148–56. doi: 10.4048/jbc.2012.15.2.148.
  14. Lal I, Dittus K, Holmes CE. Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res. 2013;15(4): 207. doi: 10.1186/bcr3425.
  15. Aceto N, Bardia A, Miyamoto DT, Donald-son MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber DA, Maheswaran S. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5): 1110–22. doi: 10.1016/j. cell.2014.07.013.
  16. Scully OJ, Bay BH, Yip G, Yu Y. Breast cancer metastasis. Cancer Genomics Proteomics. 2012;9(5): 311–20.
  17. Madjer T, Danner-Boucher I, Horeau-Langlard D, Haloun A, Lepoivre T, Sagan C, Mag-nan A. Severe pulmonary hypertension leading to heart-lung transplantation and revealing breast cancer. Eur Respir J. 2012;40(4): 1057–9. doi: 10.1183/09031936.00182711.
  18. Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H, Miyamoto A, Morokawa N, Homma S, Kishi K. Pulmonary tumor thrombotic microangiopa-thy: a clinical analysis of 30 autopsy cases. Intern Med. 2013;52(12): 1317–23. doi: http://doi.org/10.2169/internalmedicine.52.9472.
  19. Mego M, Karaba M, Minarik G, Benca J, Sedlácková T, Tothova L, Vlkova B, Cierna Z, Janega P, Luha J, Gronesova P, Pindak D, Fridrichova I, Celec P, Reuben JM, Cristofanilli M, Mardiak J. Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patients. Breast J. 2015;21(2): 155–60. doi: 10.1111/tbj.12388.
  20. Jorens PG, Van Marck E, Snoeckx A, Parizel PM. Nonthrombotic pulmonary embolism. Eur Respir J. 2009;34(2): 452–74. doi: 10.1183/09031936.00141708.
  21. Mabrouk B, Anis C, Hassen D, Leila A, Daoud S, Hichem K, Mohamed S, Hatem K, Mounir B. Pulmonary thromboembolism: incidence, physiopathology, diagnosis and treatment. Tunis Med. 2014;92(7): 435–47.
  22. Vlenterie M, Desar IM, van Herpen CM, Tol J. Fatal microscopic pulmonary tumour embolisms in patients with breast cancer: necessary knowledge for future medical practice. Neth J Med. 2014;72(1): 28–31.
  23. Kamouh A, Nelson A, Vats S, Powell R, Missov E. Pulmonary tumor thrombotic microangiopa-thy associated with right ventricular rupture and hemopericardium: a case report. Journal of Cardiology Cases. 2014;9(6): 230–2. doi: 10.1016/j.jccase.2014.02.006.
  24. Kim HJ, Kwak MH, Kong SY, Seong MW, Kang HS, Lee KS, Ro J. A case of locally advanced breast cancer complicated by pulmonary tumor thrombotic microangiopathy. Cancer Res Treat. 2012;44(4): 267–70. doi: 10.4143/ crt.2012.44.4.267.
  25. Nakamura H, Adachi H, Sudoh A, Yagyu H, Kishi K, Oh-ishi S, Kusama H, Hashimoto T, Matsuoka T. Subacute cor pulmonale due to tumor embolism. Intern Med. 2004;43(5): 420–2. doi: http://doi.org/10.2169/internalmedi-cine.43.420.
  26. Agnelli G, Verso M. Management of venous thromboembolism in patients with cancer. J Thromb Haemost. 2011;9 Suppl 1:316–24. doi: 10.1111/j.1538-7836.2011.04346.x.
  27. Palumbo A, Rajkumar SV, Dimopoulos MA, Richardson PG, San Miguel J, Barlogie B, Harousseau J, Zonder JA, Cavo M, Zangari M, Attal M, Belch A, Knop S, Joshua D, Sezer O, Ludwig H, Vesole D, Bladé J, Kyle R, Westin J, Weber D, Bringhen S, Niesvizky R, Waage A, von Lilienfeld-Toal M, Lonial S, Morgan GJ, Orlowski RZ, Shimizu K, Anderson KC, Boccadoro M, Durie BG, Sonneveld P, Hussein MA; International Myeloma Working Group. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia. 2008;22(2): 414–23. doi: 10.1038/sj.leu.2405062.
  28. Sutherland DE, Weitz IC, Liebman HA. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol. 2003;72(1): 43–52. doi: 10.1002/ajh.10263.
  29. Choi JW, Kim JK, Yang YJ, Kim P, Yoon KH, Yun SH. Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells. Cancer Res. 2015;75(21): 4474–82. doi: 10.1158/0008-5472.CAN-15-0684.
  30. Borsig L. Selectins facilitate carcinoma metastasis and heparin can prevent them. News Physiol Sci. 2004;19:16–21. doi: 10.1152/ nips.01450.2003.
  31. Minatsuki S, Miura I, Yao A, Abe H, Muraoka H, Tanaka M, Imamura T, Inaba T, Maki H, Hata-no M, Kinugawa K, Yao T, Fukayama M, Nagai R, Komuro I. Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic mi-croangiopathy. Int Heart J. 2015;56(2): 245–8. doi: 10.1536/ihj.14-220.
  32. Tsoi DT, Rowsell C, McGregor C, Kelly CM, Ver-ma S, Pritchard KI. Disseminated tumor embolism from breast cancer leading to multiorgan failure. J Clin Oncol. 2010;28(12):e180–3. doi: 10.1200/JCO.2009.25.1009.
  33. Ishiguro T, Takayanagi N, Ando M, Yanagisawa T, Shimizu Y, Sugita Y. Pulmonary tumor thrombotic microangiopathy responding to chemotherapy. Nihon Kokyuki Gakkai Zasshi. 2011;49(9): 681–7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Rozanov I.D., Rozanova E.A., Shirikov E.I., Balkanov A.S., Gaganov L.E., Stepanova E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies